Navigation Links
ConforMIS Moves Headquarters to Expanded Facilities in Burlington, MA
Date:8/30/2007

BURLINGTON, Mass., Aug. 30 /PRNewswire/ -- ConforMIS, a privately held medical device company dedicated to developing and marketing patient-specific orthopedic implants, today announced completion of its move to a new 15,000-sq.-foot headquarter facility in Burlington, MA.

The new facility was chosen to accommodate ConforMIS' rapid growth and marks the completion of the management team's efforts to move commercial operations to Massachusetts. The Burlington headquarter office combines operational functions that previously resided in Foster City, CA and Lexington, MA, including customer service, imaging services, and implant design. The facility will also allow ConforMIS to bring additional capabilities online in one location, such as manufacturing, rapid prototyping, product sterilization, packaging and shipping, and implant engineering and development.

"Our new headquarters will allow us to scale our operations to better support the rapid growth we have experienced over the last year and expect to see over the foreseeable future," said Patrick Hess, CEO of ConforMIS. "Not only will it accommodate the ongoing expansion of key company functions, it also gives us the ability to bring in new infrastructure that was not possible at our previous facilities."

The new offices are located at 2 Fourth Avenue, Burlington, MA 01803. The company's telephone numbers, including those for Imaging Services and Customer Service, remain the same.

About ConforMIS, Inc.

ConforMIS is a privately held medical device company whose mission is to provide best-in-class, minimally invasive implants for orthopedics and sports medicine through the use of its proprietary iFit Technology(TM). The iFit Technology is a patent-protected, software-enabled process for converting CT and MR imaging data into personalized, patient-specific implants. This "image-to-implant" technology allows for precisely sized and shaped implants that reduce or eliminate the need for cartilage or bone resection and radically simplify the surgical procedure. To date, the company has applied this technology to the knee joint and developed a comprehensive line of knee implants for all stages of osteoarthritis. For more information please visit http://www.conformis.com.

Contact:

Patrick Hess, CEO

(650) 286-4151 ext. 1102

Jong Lee, SVP Marketing

(781) 860-5111 ext. 1107

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ConforMIS, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin spaceport committee moves closer to formation
2. Sonic Foundrys Mediasite moves to podcasts
3. Blogging moves to corporate America
4. A budget that moves Wisconsin forward
5. Merge eFilm corporate merger with Canadian firm moves ahead
6. Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters
7. Rayovac to Relocate Headquarters
8. RedPrairie Establishes Asia-Pacific Headquarters in Shanghai
9. Data centers: Buyers beware of over-hyped facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... LabRoots ... and scientists from around the world, is pleased to announce the launch of a ... engineering and mathematics (STEM) fields. , This merit-based scholarship is open to all high ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, ... , Perkins joins Pennside after more than a decade with leading market research ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS 2017, ... health applications, announced a partnership with Redox, a leader in cloud-based healthcare integration ... clinical systems while keeping data secure in the cloud. , The digital health ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... division, Treximo will pair its $200M operational capacity with its strategic internal ... management in areas affecting quality and operational management. With office locations ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):